Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
140-82-9
17626-34-5
23978-09-8
31249-95-3
23978-55-4
70384-51-9
356066-46-1 | 3-[2-(2-Methoxyethoxy)ethoxy]propanal | AA019EC8 | MFCD26910955
2183440-50-6 | Cy5 Azide | AA019EFU | MFCD31580113
1210419-18-3 | 2-(2,6-Difluorophenyl)-3-fluoro-6-methylpyridine | AA019EJ9 | MFCD23163655
187795-44-4 | 3-Cyclobutyl-1-phenyl-1h-pyrazol-5-amine | AA019EM7 | MFCD11105318
169750-60-1 | BENZYL 4-((TERT-BUTOXYCARBONYL)AMINO)-4-METHYLPIPERIDINE-1-CARBOXYLATE | AA019EPG | MFCD23099450
911227-80-0 | tert-Butyl5-(methoxymethoxy)-4-oxospiro[chroman-2,4-piperidine]-1-carboxylate | AA019ESM | MFCD31656875
68890-19-7 | 2-CYCLOHEXEN-1-ONE, 3-[(2-BROMOPHENYL)AMINO]- | AA019EW4 | MFCD01168838
1771972-20-3 | 4-bromo-2-fluoro-N-(5-fluoro-2-methylphenyl)benzenesulfonamide | AA019EZ0 | MFCD27975684
473-15-4 | Beta-Eudesmol | AA019FS9 | MFCD00210502
53305-12-7 | Methyl 2-[4-(chlorosulfonyl)phenyl]acetate | AA019GB1 | MFCD16084560